Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Journal of Clinical Oncology · 10.11.2026 · 44 (32) · 3176-3177
DOI: 10.1200/jco-26-00962 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.11.2026. Verfasst von Ahmet Oruç und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ahmet Oruç, MD, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey, Mustafa Erol, MD; and Department of Nuclear Medicine, Ne…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Ahmet Oruç, MD, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey, Mustafa Erol, MD; and Department of Nuclear Medicine, Necmettin Erbakan University, Konya, Turkey.
ORCID-Profile: Ahmet Oruç, Mustafa Erol
Zitieren
APA
Oruç, A., & Erol, M. (2026). Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide. Journal of Clinical Oncology, 44(32), 3176-3177. https://doi.org/10.1200/jco-26-00962
Vancouver
Oruç A, Erol M. Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide. Journal of Clinical Oncology. 2026;44(32):3176-3177. doi:10.1200/jco-26-00962
BibTeX
@article{Oru2026,
author = {Oruç, Ahmet and Erol, Mustafa},
title = {Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {32},
pages = {3176--3177},
doi = {10.1200/jco-26-00962}
}
EUVIMED